Kisspeptin-10 Reconstitution Chart (Every Vial Size)

Kisspeptin-10 is an essential research peptide studied extensively for its role as an upstream regulator of the hypothalamic-pituitary-gonadal (HPG) axis. Achieving rigorous assay reproducibility requires accurate, standardized diluent calculations and precise micro-volumetric handling during laboratory preparation. This kisspeptin-10 reconstitution chart serves as a reference guide for laboratory investigators working with 2mg, 5mg, and 10mg vial configurations.

GMP-compliant U.S. facilities
ISO 17025 third-party COAs
100% domestic — no imports
Fast tracked domestic shipping
Shop research peptides

Quick answer

Kisspeptin-10 is an essential research peptide studied extensively for its role as an upstream regulator of the hypothalamic-pituitary-gonadal (HPG) axis. Achieving rigorous assay reproducibility requires accurate, standardized diluent calculations and precise micro-volumetric handling during laboratory preparation. This kisspeptin-10 reconstitution chart serves as a reference guide for laboratory investigators working with 2mg, 5mg, and 10mg vial configurations.

Reviewed by PX1 Research scientific team

Key takeaways

  • [Kisspeptin](/research-peptides/kisspeptin-10)-10 is a naturally derived, 10-amino-acid peptide fragment (YNWNSFGLRF-NH2) representing the minimal active sequence of the broader KISS1 gene product.
  • Reconstitution calculations rely on basic mass-to-volume stoichiometry.
  • The following master reference table details resulting concentrations and 0.1 mL (100 µL) micro-aliquot content across standard laboratory vial sizes (2 mg, 5 mg, and 10 mg) and common diluent volumes.
  • Reconstituting [kisspeptin](/research-peptides/kisspeptin-10)-10 requires strict adherence to aseptic techniques inside a certified laminar flow hood to prevent microbial contamination or enzymatic cleavage of the peptide chain.

Overview of Kisspeptin-10 in Preclinical Research

Kisspeptin-10 is a naturally derived, 10-amino-acid peptide fragment (YNWNSFGLRF-NH2) representing the minimal active sequence of the broader KISS1 gene product. In cellular and animal models, it serves as a primary endogenous agonist for the G-protein coupled receptor KISS1R (formerly known as GPR54). Preclinical studies suggest that binding of kisspeptin-10 to KISS1R activates intracellular phospholipase C pathways, triggering intracellular calcium mobilization and downstream stimulation of gonadotropin-releasing hormone (GnRH) neurons.

Because kisspeptin-10 exerts direct upstream control over the hypothalamic-pituitary-gonadal axis, it is heavily utilized in neuroendocrine models, reproductive physiology experiments, and signal transduction research. When sourcing high-purity Kisspeptin-10 10mg for laboratory research, researchers must ensure precise reconstitution math to maintain target concentrations across culture wells or animal administration vectors.

Mathematical Formula for Peptide Reconstitution

Reconstitution calculations rely on basic mass-to-volume stoichiometry. To establish a target concentration, the total mass of the lyophilized peptide cake in milligrams (mg) is divided by the total volume of sterile diluent added in milliliters (mL).

The fundamental formula for calculating final concentration is:

Concentration (mg/mL) = Total Mass of Peptide (mg) / Volume of Diluent Added (mL)

To convert the resulting value into micrograms per microliter (mcg/µL) or to calculate the mass contained in a 0.1 mL (100 µL) micro-aliquot, multiply the concentration in mg/mL by 100 to yield total micrograms per 0.1 mL volumetric increment. For automated calculations across complex dilutions, researchers can also utilize our interactive peptide reconstitution calculator.

Master Kisspeptin-10 Reconstitution Chart

The following master reference table details resulting concentrations and 0.1 mL (100 µL) micro-aliquot content across standard laboratory vial sizes (2 mg, 5 mg, and 10 mg) and common diluent volumes.

| Vial Size | Diluent Volume | Final Concentration (mg/mL) | Final Concentration (mcg/mL) | Peptide Mass per 0.1 mL (100 µL) | |---|---|---|---|---| | 2 mg | 1.0 mL | 2.0 mg/mL | 2,000 mcg/mL | 200 mcg (0.2 mg) | | 2 mg | 2.0 mL | 1.0 mg/mL | 1,000 mcg/mL | 100 mcg (0.1 mg) | | 2 mg | 3.0 mL | 0.67 mg/mL | 667 mcg/mL | 66.7 mcg | | 5 mg | 1.0 mL | 5.0 mg/mL | 5,000 mcg/mL | 500 mcg (0.5 mg) | | 5 mg | 2.0 mL | 2.5 mg/mL | 2,500 mcg/mL | 250 mcg (0.25 mg) | | 5 mg | 2.5 mL | 2.0 mg/mL | 2,000 mcg/mL | 200 mcg (0.2 mg) | | 5 mg | 5.0 mL | 1.0 mg/mL | 1,000 mcg/mL | 100 mcg (0.1 mg) | | 10 mg | 2.0 mL | 5.0 mg/mL | 5,000 mcg/mL | 500 mcg (0.5 mg) | | 10 mg | 2.5 mL | 4.0 mg/mL | 4,000 mcg/mL | 400 mcg (0.4 mg) | | 10 mg | 5.0 mL | 2.0 mg/mL | 2,000 mcg/mL | 200 mcg (0.2 mg) |

This table assumes complete dissolution of the lyophilized cake without significant displacement volume effects. Researchers working across our broader catalog of research peptides can apply these same volumetric principles to other lyophilized compounds.

Step-by-Step Laboratory Reconstitution Protocol

Reconstituting kisspeptin-10 requires strict adherence to aseptic techniques inside a certified laminar flow hood to prevent microbial contamination or enzymatic cleavage of the peptide chain. Begin by allowing the sealed vial to acclimate to room temperature (20°C to 25°C) for approximately 30 minutes. Reconstituting cold lyophilized peptide can introduce condensation inside the vial, altering solvent volume or promoting aggregation.

Sanitize the rubber septum of the vial using a 70% isopropyl alcohol swab and allow it to air-dry completely. Using a calibrated lab pipette or precision syringe, draw the exact pre-calculated volume of diluent (such as bacteriostatic water containing 0.9% benzyl alcohol or sterile phosphate-buffered saline). Direct the diluent stream against the inner glass wall of the vial rather than shooting it directly onto the lyophilized cake. Allow the solvent to gently wet the mass. Gently swirl the vial in a circular motion; never subject the solution to violent agitation or vortexing, as shear forces can disrupt peptide secondary structure.

Worked Example Calculations for Bench Researchers

To illustrate the practical application of the kisspeptin-10 reconstitution chart, consider two standard laboratory research scenarios.

Worked Example 1: A researcher requires a working concentration of 2.5 mg/mL from a 5 mg vial of Kisspeptin-10. Applying the reconstitution formula: Concentration = Mass / Volume 2.5 mg/mL = 5 mg / Diluent Volume Diluent Volume = 5 mg / 2.5 mg/mL = 2.0 mL. Adding 2.0 mL of diluent yields a final concentration of 2.5 mg/mL. A 0.1 mL (100 µL) micro-aliquot withdrawn from this solution contains exactly 250 mcg (0.25 mg) of Kisspeptin-10.

Worked Example 2: A bench trial requires 400 mcg of Kisspeptin-10 per test well, delivered in a 0.1 mL addition volume. The laboratory has a 10 mg vial. To achieve 400 mcg per 0.1 mL, the total concentration must be 4,000 mcg/mL (or 4.0 mg/mL). 4.0 mg/mL = 10 mg / Diluent Volume Diluent Volume = 10 mg / 4.0 mg/mL = 2.5 mL. Reconstituting the 10 mg vial with 2.5 mL of solvent yields the target 4.0 mg/mL working stock.

Comparative Analysis of HPG Axis Signaling Peptides

Kisspeptin-10 operates at the apex of the neuroendocrine cascade governing reproductive signaling. In comparative preclinical models, researchers frequently contrast kisspeptin-10 with direct GnRH receptor agonists and analogue peptides to evaluate differential gonadotropin secretion patterns.

For instance, while kisspeptin-10 acts upstream at the KISS1R receptor to stimulate endogenous GnRH release, peptides like Triptorelin and Gonadorelin bind directly to pituitary GnRH receptors downstream. In rodent models, continuous administration of direct GnRH agonists causes eventual receptor downregulation, whereas pulsatile upstream activation via kisspeptin derivatives yields distinct LH and FSH release profiles. Investigating these distinct pathways helps delineate fine-scale feedback mechanisms across the reproductive endocrine axis.

Solubility Characteristics and Diluent Compatibility

Kisspeptin-10 is a basic decapeptide with a favorable solubility profile in standard aqueous laboratory buffers. For short-term assays, sterile 0.9% sodium chloride (normal saline) or sterile water for injection (WFI) is suitable. However, for multi-use research vials intended for storage over several days at refrigerated temperatures, bacteriostatic water containing 0.9% benzyl alcohol is recommended to inhibit bacterial growth.

If solubility issues arise at high concentrations (e.g., above 10 mg/mL), adjusting the buffer pH slightly or utilizing a minimal fraction of dilute acetic acid (0.1%) prior to bringing the volume up with sterile water can facilitate complete dissolution. Avoid hyper-alkaline buffers that may induce deamidation or racemization of key amino acid residues.

Storage, Handling, and Stability Protocols

Lyophilized kisspeptin-10 supplied by PX1 Research demonstrates excellent long-term stability when stored unopened at -20°C or -80°C, protected from light and atmospheric moisture. Desiccant packs should be kept inside storage containers to prevent hydration of the lyophilized powder.

Once reconstituted, the peptide solution is significantly more susceptible to enzymatic degradation, oxidation, and surface adsorption. Reconstituted stock solutions prepared in bacteriostatic water should be stored at 2°C to 8°C and used within 14 to 21 days. For extended multi-month storage of liquid stock, freeze the solution in single-use micro-aliquots at -80°C to avoid repeated freeze-thaw cycles, which induce structural degradation and peptide aggregation.

Quality Verification: HPLC, Mass Spectrometry, and Endotoxin Standards

At PX1 Research, all research peptides are manufactured in state-of-the-art USA facilities under strict ISO 9001 and GMP-compliant conditions. Every production lot undergoes rigorous quality control testing in an independent ISO 17025 accredited analytical laboratory.

Purity is verified using High-Performance Liquid Chromatography (HPLC), guaranteeing a minimum chemical purity of 98%. Mass Spectrometry (MS) analysis confirms exact molecular weight identity, and kinetic chromogenic LAL assays ensure endotoxin levels remain below 0.05 EU/mg. Investigators can inspect lot-specific analytical reports by reviewing our published Certificates of Analysis or contact our team directly regarding wholesale lab accounts for high-volume research applications.

Frequently Asked Questions

What is Kisspeptin-10 studied for in laboratory settings?

Kisspeptin-10 is studied primarily as an upstream signaling peptide that binds to the KISS1R (GPR54) receptor, triggering the downstream release of gonadotropin-releasing hormone (GnRH) in neuroendocrine and reproductive research models.

How much bacteriostatic water should be added to a 10mg Kisspeptin-10 vial?

Diluent volume depends on your required working concentration. For example, adding 2.5 mL of bacteriostatic water to a 10 mg vial yields a concentration of 4.0 mg/mL (400 mcg per 0.1 mL aliquot). Adding 5.0 mL yields a 2.0 mg/mL concentration.

Can Kisspeptin-10 be reconstituted in normal saline?

Yes, Kisspeptin-10 is soluble in sterile 0.9% sodium chloride for acute, single-day laboratory experiments. For multi-dose vials used over several days, bacteriostatic water is preferred to inhibit microbial growth.

How should reconstituted Kisspeptin-10 stock solutions be stored?

Reconstituted liquid solutions should be stored at 2°C to 8°C for short-term use (up to 14–21 days). For long-term preservation, aliquot the stock solution into single-use micro-tubes and store at -80°C.

What is the formula to determine peptide concentration per micro-aliquot?

Concentration (mg/mL) = Total Peptide Mass (mg) / Diluent Volume (mL). To find the mass in a 0.1 mL (100 µL) volume, multiply the concentration in mg/mL by 100 to get total micrograms per 0.1 mL.

What quality assurance documentation is provided with PX1 Research peptides?

Every lot of Kisspeptin-10 from PX1 Research is shipped with a third-party ISO 17025 Certificate of Analysis (COA) confirming HPLC purity (>98%), MS identity verification, and endotoxin levels (<0.05 EU/mg).

Why should peptide solutions avoid vortexing during reconstitution?

Vortexing or aggressive shaking generates shear forces and air bubbles that can disrupt the secondary structure of the peptide, leading to denaturation or irreversible aggregation.

Where are PX1 Research compounds synthesized and shipped from?

PX1 Research peptides are manufactured in USA-based, GMP-compliant facilities. Orders are fulfilled directly from our laboratory facilities located in California and Arizona.

Related pages

All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.